Abbott SARS-CoV-2 Diagnostic Kit Recalled for Risk of False Positive Results
Abbott Molecular is recalling 60,563 units of the Alinity m SARS-CoV-2 Amp Kit due to potential false positive test results. The affected kits were distributed worldwide from September 2021 through January 2023.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: This is an FDA Class I recall, which requires a minimum severity score of 4 per the rubric. Although no illnesses or injuries have been reported in the source text, the FDA's Class I classification indicates the agency determined the potential for false positive results in a diagnostic device presents a serious health consequence.
Plain-English summary
Abbott Molecular, Inc. is recalling 60,563 units of the Alinity m SARS-CoV-2 Amp Kit (Emergency Use Authorization, US Assay) and the associated Application Specification File. The FDA classified this as a Class I recall due to the potential for false positive results.
The recalled diagnostic kits were distributed worldwide, including throughout the United States and 35 other countries. Multiple lot numbers are affected, with expiration dates ranging from September 2021 to January 2023.
The hazard is a potential for false positive results. A false positive would mean a diagnostic test could incorrectly indicate infection when a person is not actually infected. The FDA's Class I classification indicates the agency determined this risk presents a serious health consequence.
Laboratories and healthcare facilities possessing the affected kits should discontinue use and contact Abbott Molecular for information about device replacement or alternative testing options.
The recalled product
- Product
- Alinity m SARS-CoV-2 Amp Kit (Emergency Use Authorization, US Assay) and Alinity m SARS-CoV-2 Application Specification File. in vitro diagnostic
- Manufacturer
- Abbott Molecular, Inc.
- Hazard
- Affected units
- 60,563
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- List Number: 09N78-095
- UDI 00884999049222
- Lot/Serial
- Expiration: 511810
- 09/18/2021
- 512026
- 09/21/2021
- 512900
- 10/14/2021
- 513146
- 513583
- 11/18/2021
- 513959
- 11/23/2021
- 514176
- 514216
- 12/01/2021
- 514819
- 12/17/2021
- 515052
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 5 recalled by Abbott Molecular, Inc. under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 5 products in this recall →Related recalls
Same manufacturer · Abbott Molecular, Inc.
See all →- HighAbbott Alinity m Resp-4-Plex AMP Kit Multiplex PCR Test Recall
FDA (Devices) · 2025-05-21
- HighAbbott Alinity m Resp-4-Plex Amplification Kit Recall
FDA (Devices) · 2025-05-21
- ModerateAlinity m System nucleic acid testing instruments recalled for liquid spillage
FDA (Devices) · 2025-04-30
- HighAbbott Alinity m HPV test kit control failures from iron contamination
FDA (Devices) · 2024-11-06
- HighAbbott STI and HPV Test Kits Recalled for Quality Control Failures
FDA (Devices) · 2024-11-06
Same hazard · false positive
See all →- HighHealthmark ProChek-II Medical Tests Recalled for Expired Ingredient
FDA (Devices) · 2026-09-02
- HighAmyloid 1-42-N plasma calibrators recalled over falsely elevated results
FDA (Devices) · 2026-02-11
- HighpTau 217 plasma cartridges recalled over falsely elevated ratio results
FDA (Devices) · 2026-02-11
- HighpTau 217 plasma calibrators recalled over falsely elevated ratio results
FDA (Devices) · 2026-02-11
- HighAmyloid plasma controls recalled over falsely elevated ratio results
FDA (Devices) · 2026-02-11